Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Boehringer-Ingelheim
Company Monitoring Page for Boehringer-Ingelheim
latest headlines for company on cafepharma
GoodRx teams with Boehringer on Humira biosimilar
Axios
Thu, 07/18/24 - 11:21 am
Tags:
GoodRx
,
Boehringer Ingelheim
,
biosimilars
,
Humira
Boehringer backs Brainomix AI software for lung fibrosis
Pharmaphorum
Thu, 07/18/24 - 11:08 am
Tags:
Boehringer Ingelheim
,
digital health
,
lung fibrosis
,
Brainomix
,
artificial intelligence
Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling
BioSpace
Mon, 07/8/24 - 11:38 am
Tags:
Boehringer Ingelheim
,
Inflation Reduction Act
,
legal
,
Medicare
,
drug pricing
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena
Tue, 07/2/24 - 11:19 am
Tags:
Boehringer Ingelheim
,
Gubra
,
clinical trials
,
BI 3034701
,
obesity
With 2 planned launches, Boehringer Ingelheim looks to make a name for itself in oncology
Fierce Pharma
Mon, 06/10/24 - 06:07 pm
Tags:
Boehringer Ingelheim
,
oncology
,
ASCO 2024
,
DDLPS
,
glioblastoma
Boehringer, Lilly face off in MASH at EASL
Pharmaphorum
Mon, 06/10/24 - 11:14 am
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
MASH
,
EASL
,
tirzepatide
,
survodutide
Boehringer, Zealand’s GLP-1 MASH Data ‘Unintentionally’ Published by Medical Congress Website
BioSpace
Thu, 06/6/24 - 11:48 am
Tags:
Zealand Pharma
,
Boehringer Ingelheim
,
MASH
,
survodutide
,
clinical trials
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
Tags:
R&D
,
Novartis
,
Argo Biopharmaceutical
,
Roche
,
MOMA Therapeutics
,
Boehringer Ingelheim
,
Suzhou Ribo Life Science
,
Eli Lilly
,
Isomorphic Labs
,
Merus
,
Gilead Sciences
,
Novo Nordisk
,
Neomorph
,
AbbVie
,
Umoja Biopharma
,
Merck KGaA
,
Caris Life Sciences
,
Voyager Therapeutics
Boehringer outlines up to $33.6m for cancer asset from OSE Therapeutics
Clinical Trials Arena
Thu, 05/23/24 - 09:43 pm
Tags:
Boehringer Ingelheim
,
OSE Immunotherapeutics
,
oncology
Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset
Fierce Biotech
Wed, 05/22/24 - 11:31 am
Tags:
Boehringer Ingelheim
,
OSE Immunotherapeutics
,
cardiovascular disease
,
solid tumors
Boehringer, Walgreens Team Up for Obesity Trial as Weight-Loss Drug Race Heats Up
BioSpace
Mon, 05/6/24 - 11:33 am
Tags:
Boehringer Ingelheim
,
Walgreens
,
obesity
,
type 2 diabetes
,
clinical trials
,
survodutide
FDA Approval Fuels Boehringer’s Biosimilar Challenge to AbbVie’s Humira
BioSpace
Thu, 05/2/24 - 11:37 am
Tags:
Boehringer Ingelheim
,
Cyltezo
,
AbbVie
,
Huira
,
FDA
,
biosimilars
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Fierce Biotech
Mon, 04/22/24 - 11:44 am
Tags:
Boehringer Ingelheim
,
Ochre Bio
,
RNA
,
MASH
,
NASH
Jardiance doesn’t cut it in post-heart attack trial
Pharmaphorum
Mon, 04/8/24 - 11:21 am
Tags:
Boehringer Ingelheim
,
Eli Lilly
,
Jardiance
,
clinical trials
,
heart attack
Boehringer to lay off salespeople as Humira biosimilar sales lag
Reuters
Fri, 04/5/24 - 11:33 am
Tags:
Boehringer Ingelheim
,
AbbVie
,
Humira
,
biosimilars
,
layoffs
GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month
Fierce Pharma
Thu, 03/21/24 - 06:37 pm
Tags:
GSK
,
Boehringer Ingelheim
,
AstraZeneca
,
drug pricing
,
COPD
,
asthma
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers
Reuters
Mon, 03/18/24 - 11:05 am
Tags:
AstraZeneca
,
inhalers
,
drug pricing
,
Boehringer Ingelheim
,
Airsupra
,
Bevespi Aerosphere
,
Breztri Aerosphere
,
COPD
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
BioSpace
Sun, 03/17/24 - 09:25 pm
Tags:
Asgard Therapeutics
,
JNJ
,
Novo Nordisk
,
Boehringer Ingelheim
,
funding
,
immuno-oncology
Boehringer licenses Sosei schizophrenia drugs in €755m deal
Pharmaphorum
Mon, 03/11/24 - 11:40 am
Tags:
Boehringer Ingelheim
,
schizophrenia
,
Sosei
Boehringer to cap out-of-pocket inhaler cost at $35 per month
Reuters
Thu, 03/7/24 - 11:08 am
Tags:
Boehringer Ingelheim
,
drug pricing
,
Atrovent
,
Combivent Respimat
,
Spiriva HandiHale
,
COPD
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.